PURPOSE: We investigated the synthesis and physical, chemical and biological characterisation of a carboxymethyl-dextran polymer substituted with the paramagnetic macrocyclic complex Gd-DOTA using an amino spacer. MATERIAL AND METHODS: The product was synthesised in 4 steps. Using rigorous purification conditions in each step, a polymer was obtained, i.e. CMD-A2-Gd-DOTA, whose polydispersity profile was comparable to the initial dextran (I = 1.66-Mw = 50.5 kDa). Approximately 22% of the glucose groups were replaced by Gd-DOTA and 39% were replaced by carboxyl groups. The paramagnetic efficacy of the polymer was 3 times higher than Gd-DOTA alone, which suggests that the injected doses of Gd(III) can be reduced. The vascular residence time of the polymer was measured in rats and rabbits, showing that the pharmacokinetics of the product is similar whatever the dose. Forty-five percent of the product was excreted in urine after 24 h and 1.64% was found in the liver. No acute toxicity was observed at the maximum dose injected (> 5 mmol Gd/kg) and the general biocompatibility of the product tested in vitro was comparable to that of Gd-DOTA. RESULTS AND CONCLUSION: These results show the advantages of using paramagnetic macrocyclic complexes in the synthesis of macromolecules to preserve biological stability, in contrast with linear chelates. Additional studies will be carried out to demonstrate the benefits of this type of product, particularly in functional imaging.
PURPOSE: We investigated the synthesis and physical, chemical and biological characterisation of a carboxymethyl-dextran polymer substituted with the paramagnetic macrocyclic complex Gd-DOTA using an amino spacer. MATERIAL AND METHODS: The product was synthesised in 4 steps. Using rigorous purification conditions in each step, a polymer was obtained, i.e. CMD-A2-Gd-DOTA, whose polydispersity profile was comparable to the initial dextran (I = 1.66-Mw = 50.5 kDa). Approximately 22% of the glucose groups were replaced by Gd-DOTA and 39% were replaced by carboxyl groups. The paramagnetic efficacy of the polymer was 3 times higher than Gd-DOTA alone, which suggests that the injected doses of Gd(III) can be reduced. The vascular residence time of the polymer was measured in rats and rabbits, showing that the pharmacokinetics of the product is similar whatever the dose. Forty-five percent of the product was excreted in urine after 24 h and 1.64% was found in the liver. No acute toxicity was observed at the maximum dose injected (> 5 mmol Gd/kg) and the general biocompatibility of the product tested in vitro was comparable to that of Gd-DOTA. RESULTS AND CONCLUSION: These results show the advantages of using paramagnetic macrocyclic complexes in the synthesis of macromolecules to preserve biological stability, in contrast with linear chelates. Additional studies will be carried out to demonstrate the benefits of this type of product, particularly in functional imaging.
Authors: M Port; D Meyer; B Bonnemain; C Corot; M Schaefer; O Rousseaux; C Simonot; P Bourrinet; S Benderbous; A Dencausse; L Devoldere Journal: MAGMA Date: 1999-08 Impact factor: 2.310
Authors: Anda Preda; Viktor Novikov; Martina Möglich; Eugenia Floyd; Karl Turetschek; David M Shames; Timothy P L Roberts; Claire Corot; Wayne O Carter; Robert C Brasch Journal: Eur Radiol Date: 2005-07-13 Impact factor: 5.315
Authors: L Chaabane; N Pellet; M C Bourdillon; C Desbleds Mansard; A Sulaiman; G Hadour; F Thivolet-Béjui; P Roy; A Briguet; P Douek; E Canet Soulas Journal: MAGMA Date: 2004-11-25 Impact factor: 2.310
Authors: M Port; C Corot; O Rousseaux; I Raynal; L Devoldere; J M Idée; A Dencausse; S Le Greneur; C Simonot; D Meyer Journal: MAGMA Date: 2001-05 Impact factor: 2.533